Maturation LevelNCT07920146
Biological Maturation, Athletic Performance, and Injury Risk in Adolescent Male Soccer Players
An observational study of Maturation Level and Football Players, run by Alanya Alaaddin Keykubat University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to investigate the relationship between biological maturation, athletic performance, and injury risk in adolescent male soccer players. Participants aged 14-19 years will be recruited from a professional soccer academy. Read more about this study
- Who is it for?
- Ages 14 to 19 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Maturation Level, Football Players, Injuries; Muscle, Nontraumatic
- What is being tested?
- Anthropometric and Performance Assessment.
- How many people
- 106 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 May 2025to 15 May 2026
- How long will I take part?
- 1 Week
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 19 years
- Men only
- Healthy volunteers accepted
- Child, Adult
Study population: Adolescent male soccer players aged 14-19 years, actively participating in regular training and competition within a professional soccer academy, will constitute the study population.
Who may be able to join
- Male soccer players aged 14 to 19 years
- Licensed athletes with at least 1 year of sports experience
- Actively participating in training and competitions
- Registered in a professional soccer club academy
- Able to understand and follow test instructions
Who cannot join
- Any health problem occurring during the assessment period
- Inability to complete performance tests at the required level
- Irregular participation in study assessments
- History of surgery within the past year
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Alanya Alaaddin Keykubat University
Antalya, Alanya, 07400
About this study
Official title: The Relationship Between Biological Maturation, Athletic Performance, and Injury Risk in Adolescent Male Soccer Players: A Cross-Sectional Study
This study aims to investigate the relationship between biological maturation, athletic performance, and injury risk in adolescent male soccer players. Participants aged 14-19 years will be recruited from a professional soccer academy. Biological maturation status will be assessed using maturity offset calculations, while athletic performance will be evaluated through standardized tests including agility, balance, strength, and aerobic capacity. Injury risk will be assessed using functional movement screening. The findings are expected to provide insights into the role of maturation in performance and injury risk in youth soccer players.
- Conditions
- Maturation Level, Football Players, Injuries; Muscle, Nontraumatic, Prevention, Performance
- Being tested
- Anthropometric and Performance Assessment.
- Keywords
- Maturation, injuries, football,performance,prevention
- Medical subject headings
- Wounds and Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Anthropometric and Performance Assessment.Other
Participants will undergo a structured evaluation protocol including anthropometric measurements, athletic performance tests (e.g., agility, strength, balance, and aerobic capacity), and injury risk assessment using functional movement screening. No therapeutic or experimental intervention will be applied.
| Study group | Role | What they receive |
|---|---|---|
| Adolescent Male Football Players | Participants aged 14-19 years who are actively competing in a professional football academy and undergoing assessment of biological maturation, athletic performance, and injury risk parameters. Receives: Other: Anthropometric and Performance Assessment. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Estimated Maturity Offset
Biological maturation was estimated using the male-specific Mirwald maturity-offset equation based on decimal chronological age, standing height, sitting height, derived leg length, and body mass. Decimal chronological age was calculated using May 1, 2025 as the common reference date. The outcome was estimated time from peak height velocity (PHV), expressed in years. Negative values indicate time before estimated PHV and positive values indicate time after estimated PHV. This measure is an anthropometric estimate of maturation rather than a direct measurement of biological age.
Measured: Baseline
Functional Movement Screen Total Score
Functional movement quality was assessed using the Functional Movement Screen (FMS). Seven movement patterns were scored from 0 to 3: deep squat, hurdle step, in-line lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, and rotary stability. A score of 3 indicates performance meeting the standard criteria, 2 indicates compensatory movement, 1 indicates inability to meet the criteria, and 0 indicates pain. For bilateral items, the lower of the two side scores contributed to the total. The seven item scores were summed to give a total score from 0 to 21 points. Higher scores indicate better functional movement quality.
Measured: Baseline
Final Running Speed in the 30-15 Intermittent Fitness Test
Intermittent running performance was assessed using the 30-15 Intermittent Fitness Test on a 40-m shuttle course. The test consisted of 30-second running stages separated by 15-second recovery periods. Running speed started at 8 km/h and increased by 0.5 km/h at each stage. Participants followed audio signals until they could no longer maintain the required pace or continue the test. The outcome was the speed of the last completed stage, recorded in kilometers per hour (km/h). Higher values indicate better intermittent running performance.
Measured: Baseline
Pro-Agility Test Completion Time
Change-of-direction performance was assessed using the Pro-Agility Test. Markers were placed 5 yards (4.57 m) to either side of the central starting line. From the central line, the participant moved to and touched the right marker, then the left marker, and returned through the central line. Completion time was measured using a photocell timing system at the central line and recorded in seconds. Lower values indicate faster completion and better change-of-direction performance.
Measured: Baseline
Hamstring Isometric Strength
Hamstring isometric strength was assessed using an Active Force 2 digital handheld dynamometer. The participant lay prone with the knee flexed to approximately 90 degrees and performed three maximal isometric knee-flexion contractions lasting approximately 3 to 5 seconds each, with 30 seconds of rest between trials. The highest force recorded across the three trials was used as the outcome and expressed in newtons (N). Higher values indicate greater hamstring isometric strength.
Measured: Baseline
Quadriceps Isometric Strength
Quadriceps isometric strength was assessed using an Active Force 2 digital handheld dynamometer. The participant sat with the hip and knee flexed to approximately 90 degrees and performed three maximal isometric knee-extension contractions lasting approximately 3 to 5 seconds each, with 30 seconds of rest between trials. The highest force recorded across the three trials was used as the outcome and expressed in newtons (N). Higher values indicate greater quadriceps isometric strength.
Measured: Baseline
Number of Balance Errors in the Flamingo Balance Test
Static balance was assessed using the Flamingo Balance Test. The participant maintained a single-leg stance for [CONFIRMED TEST DURATION]. Touching the ground with the non-supporting foot, moving the supporting foot, or losing balance was counted as an error. The total number of balance errors during the assessment was recorded as a count. Lower values indicate better static balance.
Measured: Baseline
Mean Seated Medicine Ball Chest Pass Distance
Upper-body explosive performance was assessed using a seated chest pass with a 3-kg medicine ball. The participant sat with the knees extended and the back, shoulders, and head against a wall. The ball was thrown as far as possible from chest level using both hands while maintaining contact with the wall. After warm-up and practice attempts, four valid throws were performed with 30 to 45 seconds of rest between throws. The arithmetic mean of the four throwing distances was recorded in meters (m). Higher values indicate better throwing performance.
Measured: Baseline
Right Anterior Normalized Reach Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. After practice attempts, three valid reaches were recorded in the anterior direction. The greatest valid reach distance was divided by the length of the right lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Measured: Baseline
Right Posteromedial Normalized Reach Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. After practice attempts, three valid reaches were recorded in the posteromedial direction. The greatest valid reach distance was divided by the length of the right lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Measured: Baseline
Right Posterolateral Normalized Reach Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. After practice attempts, three valid reaches were recorded in the posterolateral direction. The greatest valid reach distance was divided by the length of the right lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Measured: Baseline
Right Composite Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. The greatest valid reach distance from three trials in each of the anterior, posteromedial, and posterolateral directions was used. The three distances were summed, divided by three times the length of the right lower limb, and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The composite score was expressed as a percentage of limb length. Higher values indicate greater overall reach relative to limb length.
Measured: Baseline
Left Anterior Normalized Reach Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. After practice attempts, three valid reaches were recorded in the anterior direction. The greatest valid reach distance was divided by the length of the left lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Measured: Baseline
Left Posteromedial Normalized Reach Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. After practice attempts, three valid reaches were recorded in the posteromedial direction. The greatest valid reach distance was divided by the length of the left lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Measured: Baseline
Left Posterolateral Normalized Reach Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. After practice attempts, three valid reaches were recorded in the posterolateral direction. The greatest valid reach distance was divided by the length of the left lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Measured: Baseline
Left Composite Score on the Y Balance Test
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. The greatest valid reach distance from three trials in each of the anterior, posteromedial, and posterolateral directions was used. The three distances were summed, divided by three times the length of the left lower limb, and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The composite score was expressed as a percentage of limb length. Higher values indicate greater overall reach relative to limb length.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Nov 2026
- Study start15 May 2025
- Primary completion16 May 2025
- Study completion15 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Maturation LevelStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 106 participants (actual)
- Target duration
- 1 Week
Sponsor and investigators
- Lead sponsor
- Alanya Alaaddin Keykubat University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ayça Araci, Alanya Alaaddin Keykubat University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07920146
- Sponsor's protocol ID
- 15.04.2026
- Status last verified
- Nov 2026
- First submitted
- 15 Apr 2026
- Last updated
- 5 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared due to ethical and legal restrictions related to the protection of personal data. Although data will be de-identified, there remains a potential risk of re-identification. Therefore, all data will be stored securely and used solely for research purposes in accordance with institutional and national data protection regulations.
Study at a glance
From the registry record, last updated by the sponsor on 5 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Relationship Between Biological Maturation, Athletic Performance, and Injury Risk in Adolescent Male Soccer Players: A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT07920146
- Acronym / sponsor ID
- 15.04.2026
- Conditions
- Maturation Level, Football Players, Injuries; Muscle, Nontraumatic, Prevention, Performance
- Keywords
- Maturation, injuries, football,performance,prevention
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 106 participants (actual)
- Lead sponsor
- Alanya Alaaddin Keykubat UniversityUniversity, hospital or other
- Study start
- 15 May 2025 (actual)
- Primary completion
- 16 May 2025 (actual)
- Study completion
- 15 May 2026 (actual)
- First posted
- 5 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the relationship between biological maturation, athletic performance, and injury risk in adolescent male soccer players. Participants aged 14-19 years will be recruited from a professional soccer academy. Biological maturation status will be assessed using maturity offset calculations, while athletic performance will be evaluated through standardized tests including agility, balance, strength, and aerobic capacity. Injury risk will be assessed using functional movement screening. The findings are expected to provide insights into the role of maturation in performance and injury risk in youth soccer players.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Week
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Adolescent Male Football Players | – | Other: Anthropometric and Performance Assessment.Participants aged 14-19 years who are actively competing in a professional football academy and undergoing assessment of biological maturation, athletic performance, and injury risk parameters. |
Who may qualify
- Ages
- 14 to 19 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Adolescent male soccer players aged 14-19 years, actively participating in regular training and competition within a professional soccer academy, will constitute the study population.
Key inclusion criteria (5 listed)
- Male soccer players aged 14 to 19 years
- Licensed athletes with at least 1 year of sports experience
- Actively participating in training and competitions
- Registered in a professional soccer club academy
- Able to understand and follow test instructions
Key exclusion criteria (4 listed)
- Any health problem occurring during the assessment period
- Inability to complete performance tests at the required level
- Irregular participation in study assessments
- History of surgery within the past year
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Anthropometric and Performance Assessment.Participants will undergo a structured evaluation protocol including anthropometric measurements, athletic performance tests (e.g., agility, strength, balance, and aerobic capacity), and injury risk assessment using functional movement screening. No therapeutic or experimental intervention will be applied. | Other | Adolescent Male Football Players |
Primary outcome
Estimated Maturity Offset
Time frame: Baseline
Biological maturation was estimated using the male-specific Mirwald maturity-offset equation based on decimal chronological age, standing height, sitting height, derived leg length, and body mass. Decimal chronological age was calculated using May 1, 2025 as the common reference date. The outcome was estimated time from peak height velocity (PHV), expressed in years. Negative values indicate time before estimated PHV and positive values indicate time after estimated PHV. This measure is an anthropometric estimate of maturation rather than a direct measurement of biological age.
Functional Movement Screen Total Score
Time frame: Baseline
Functional movement quality was assessed using the Functional Movement Screen (FMS). Seven movement patterns were scored from 0 to 3: deep squat, hurdle step, in-line lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, and rotary stability. A score of 3 indicates performance meeting the standard criteria, 2 indicates compensatory movement, 1 indicates inability to meet the criteria, and 0 indicates pain. For bilateral items, the lower of the two side scores contributed to the total. The seven item scores were summed to give a total score from 0 to 21 points. Higher scores indicate better functional movement quality.
Final Running Speed in the 30-15 Intermittent Fitness Test
Time frame: Baseline
Intermittent running performance was assessed using the 30-15 Intermittent Fitness Test on a 40-m shuttle course. The test consisted of 30-second running stages separated by 15-second recovery periods. Running speed started at 8 km/h and increased by 0.5 km/h at each stage. Participants followed audio signals until they could no longer maintain the required pace or continue the test. The outcome was the speed of the last completed stage, recorded in kilometers per hour (km/h). Higher values indicate better intermittent running performance.
Pro-Agility Test Completion Time
Time frame: Baseline
Change-of-direction performance was assessed using the Pro-Agility Test. Markers were placed 5 yards (4.57 m) to either side of the central starting line. From the central line, the participant moved to and touched the right marker, then the left marker, and returned through the central line. Completion time was measured using a photocell timing system at the central line and recorded in seconds. Lower values indicate faster completion and better change-of-direction performance.
Hamstring Isometric Strength
Time frame: Baseline
Hamstring isometric strength was assessed using an Active Force 2 digital handheld dynamometer. The participant lay prone with the knee flexed to approximately 90 degrees and performed three maximal isometric knee-flexion contractions lasting approximately 3 to 5 seconds each, with 30 seconds of rest between trials. The highest force recorded across the three trials was used as the outcome and expressed in newtons (N). Higher values indicate greater hamstring isometric strength.
Quadriceps Isometric Strength
Time frame: Baseline
Quadriceps isometric strength was assessed using an Active Force 2 digital handheld dynamometer. The participant sat with the hip and knee flexed to approximately 90 degrees and performed three maximal isometric knee-extension contractions lasting approximately 3 to 5 seconds each, with 30 seconds of rest between trials. The highest force recorded across the three trials was used as the outcome and expressed in newtons (N). Higher values indicate greater quadriceps isometric strength.
Number of Balance Errors in the Flamingo Balance Test
Time frame: Baseline
Static balance was assessed using the Flamingo Balance Test. The participant maintained a single-leg stance for [CONFIRMED TEST DURATION]. Touching the ground with the non-supporting foot, moving the supporting foot, or losing balance was counted as an error. The total number of balance errors during the assessment was recorded as a count. Lower values indicate better static balance.
Mean Seated Medicine Ball Chest Pass Distance
Time frame: Baseline
Upper-body explosive performance was assessed using a seated chest pass with a 3-kg medicine ball. The participant sat with the knees extended and the back, shoulders, and head against a wall. The ball was thrown as far as possible from chest level using both hands while maintaining contact with the wall. After warm-up and practice attempts, four valid throws were performed with 30 to 45 seconds of rest between throws. The arithmetic mean of the four throwing distances was recorded in meters (m). Higher values indicate better throwing performance.
Right Anterior Normalized Reach Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. After practice attempts, three valid reaches were recorded in the anterior direction. The greatest valid reach distance was divided by the length of the right lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Right Posteromedial Normalized Reach Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. After practice attempts, three valid reaches were recorded in the posteromedial direction. The greatest valid reach distance was divided by the length of the right lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Right Posterolateral Normalized Reach Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. After practice attempts, three valid reaches were recorded in the posterolateral direction. The greatest valid reach distance was divided by the length of the right lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Right Composite Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the right leg as the stance limb. The greatest valid reach distance from three trials in each of the anterior, posteromedial, and posterolateral directions was used. The three distances were summed, divided by three times the length of the right lower limb, and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The composite score was expressed as a percentage of limb length. Higher values indicate greater overall reach relative to limb length.
Left Anterior Normalized Reach Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. After practice attempts, three valid reaches were recorded in the anterior direction. The greatest valid reach distance was divided by the length of the left lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Left Posteromedial Normalized Reach Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. After practice attempts, three valid reaches were recorded in the posteromedial direction. The greatest valid reach distance was divided by the length of the left lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Left Posterolateral Normalized Reach Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. After practice attempts, three valid reaches were recorded in the posterolateral direction. The greatest valid reach distance was divided by the length of the left lower limb and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The outcome was expressed as a percentage of limb length. Higher values indicate greater reach relative to limb length.
Left Composite Score on the Y Balance Test
Time frame: Baseline
Dynamic balance was assessed using the Y Balance Test with the left leg as the stance limb. The greatest valid reach distance from three trials in each of the anterior, posteromedial, and posterolateral directions was used. The three distances were summed, divided by three times the length of the left lower limb, and multiplied by 100. Lower-limb length was measured from the anterior superior iliac spine to the medial malleolus. The composite score was expressed as a percentage of limb length. Higher values indicate greater overall reach relative to limb length.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Nov 2026.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared due to ethical and legal restrictions related to the protection of personal data. Although data will be de-identified, there remains a potential risk of re-identification. Therefore, all data will be stored securely and used solely for research purposes in accordance with institutional and national data protection regulations.
Related trials for Maturation Level
Recruiting
A Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in Children
Nutrient Gap in Children, Pediatric Health and Well-Being
Recruiting
Methyl Donor-Rich Diet in the Postpartum Period
Postpartum Depression (PPD), Breastfeeding
Recruiting
Machine Learning for Evaluating and Diagnosing Temporomandibular Disorders
Temporomandibular Disorders (TMD), TMJ Disorder
Recruiting
The Effect of Triple P Training on Children's Repetitive Behaviors and Parents' Mood and Burnout Levels in Parents of Children With Autism
Autism Spectrum Disorder
RecruitingObservational study
Flexibility and the Predictive Brain in Autistic Males and Females
Autism Spectrum Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Maturation Level and Football Players, run by Alanya Alaaddin Keykubat University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Estimated Maturity Offset (time frame: Baseline). The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.